Vol. 5, Issue 1, 2017July 21, 2017 EDT
One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States
One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States
1.
Blanchette CM, Zacherle E, Noone JM, Van Doren BA, Roy D, Howden R. One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States. JHEOR. 2017;5(1):65-74. doi:10.36469/9799
